Answers are grounded in this paper and cite their sources.
Graphical review highlights the evolution of activity-based protein profiling, indicating its impact on drug discovery.
Activity-based protein profiling (ABPP) is a chemoproteomic technology that employs small chemical probes to directly interrogate protein function within complex proteomes. Since its initial application almost 25 years ago, ABPP has proven to be a powerful and versatile tool for addressing numerous challenges in drug discovery, including the development of highly selective small-molecule inhibitors, the discovery of new therapeutic targets, and the illumination of target proteins in tissues and organisms. This graphical review provides an overview of the rapid evolution of ABPP strategies, highlighting the versatility of the approach with selected examples of its successful application.
No takes yet. Share an insight, caveat, or question.
Porta et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: